Literature DB >> 19336218

Up-regulation of the expression of costimulatory molecule CD40 in hepatocytes by hepatitis B virus X antigen.

Yuyu Tang1, Yongwen Chen, Bing Ni, Di Yang, Sheng Guo, Yuzhang Wu.   

Abstract

Hepatitis B virus (HBV) is a major causative agent of hepatocellular carcinoma (HCC) but the pathogenesis remains poorly understood. To provide novel insights into the pathogenesis of HBV, we examined the expression profile of HBV-positive HepG2.2.15 and -negative HepG2 cells. Genes that were markedly up- or down-regulated in the presence of HBV are involved in signal transduction, apoptosis, transcriptional regulation, protein degradation and oncogenesis. Among the analyzed co-signaling molecules CD40, CD80, CD86, B7-H1, B7-DC, OX40, and B7RP-1, CD40 was the only one up-regulated. Following establishment of stable HepG2 cell lines transfected with HBV genes, we found that HBxAg up-regulated the expression of CD40. We also found that CD40 activation by CD40L could promote the expression of negative co-signaling molecule B7-H1, rather than induce the apoptosis of HepG2HBx cell as expected. These results suggest that CD40 up-regulation by HBxAg may play a facilitating role in the pathogenesis causing HCC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19336218     DOI: 10.1016/j.bbrc.2009.03.139

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Hypermethylation of the gene LARP2 for noninvasive prenatal diagnosis of β-thalassemia based on DNA methylation profile.

Authors:  Tian Gao; Yanli Nie; Jianxin Guo
Journal:  Mol Biol Rep       Date:  2012-02-11       Impact factor: 2.316

2.  Parenchymal expression of CD40 exacerbates adenovirus-induced hepatitis in mice.

Authors:  Jiabin Yan; Zuliang Jie; Lifei Hou; Joao L Wanderley; Lynn Soong; Shalini Gupta; Suimin Qiu; Tehsheng Chan; Jiaren Sun
Journal:  Hepatology       Date:  2011-05       Impact factor: 17.425

3.  Efficacy of early treatment on 52 patients with preneoplastic hepatitis B virus-associated hepatocellular carcinoma by compound Phyllanthus Urinaria L.

Authors:  Guang-dong Tong; Xi Zhang; Da-qiao Zhou; Chun-shan Wei; Jin-song He; Chun-ling Xiao; Xin-liang Liu; Ying-jun Zheng; Si-nuan Chen; Hai-hong Tang
Journal:  Chin J Integr Med       Date:  2013-03-25       Impact factor: 1.978

4.  Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.

Authors:  Bo Hong; Yun Qian; Hong Zhang; Yi-Wen Sang; Lin-Fang Cheng; Qi Wang; Song Gao; Min Zheng; Hang-Ping Yao
Journal:  World J Gastroenterol       Date:  2016-05-14       Impact factor: 5.742

5.  Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates.

Authors:  Marnix Lameijer; Tina Binderup; Mandy M T van Leent; Max L Senders; Francois Fay; Joost Malkus; Brenda L Sanchez-Gaytan; Abraham J P Teunissen; Nicolas Karakatsanis; Philip Robson; Xianxiao Zhou; Yuxiang Ye; Gregory Wojtkiewicz; Jun Tang; Tom T P Seijkens; Jeffrey Kroon; Erik S G Stroes; Andreas Kjaer; Jordi Ochando; Thomas Reiner; Carlos Pérez-Medina; Claudia Calcagno; Edward A Fisher; Bin Zhang; Ryan E Temel; Filip K Swirski; Matthias Nahrendorf; Zahi A Fayad; Esther Lutgens; Willem J M Mulder; Raphaël Duivenvoorden
Journal:  Nat Biomed Eng       Date:  2018-04-16       Impact factor: 25.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.